Telcare Receives 2014 CES Innovations Design and Engineering Award
The Telcare Blood Glucose Monitor®, an honoree in the health and fitness category, on display at CES this week in Telcare booth
Telcare’s Blood Glucose Monitoring System is a revolutionary diabetes management system that transmits glucose values instantly to a secure server where patients and their physicians can easily access the information. Automated and doctor-directed guidance is simultaneously displayed on the meter, on patients’ and their loved ones’ phones, and on a secure patient portal. The data from Telcare’s meter can also go directly to the medical records of any doctor that the patient selects.
“It is a great honor to be recognized by CES as a leading technology in health and fitness,” said Dr. Jonathan Javitt, CEO of Telcare and inventor of the product. “More than 30 million Americans suffer from diabetes, and with more being diagnosed every day, healthcare costs for patients and employers are rising. Telcare’s innovative product has the potential to change the way patients and physicians view and manage this chronic condition.”
The Innovations Awards have been recognizing achievements in product design and engineering since 1976. Products chosen as an Innovations honoree reflect innovative design and engineering of the entries. Examples may include the first time various technologies are combined in a single product or dramatic enhancements to previous product designs.
Telcare’s blood glucose monitoring solution is on display this week at the 2014 International CES in the Las Vegas Convention Center until January 10, 2014 in booth 25930.
Telcare uses award-winning cellular machine-to-machine technology to bridge the last mile between patients and their caregivers in order to improve the care of chronic illness. Telcare’s first product is the Telcare BGM®, a cellular-enabled blood glucose meter for patients with diabetes. In addition to directly reducing the cost of care by improving outcomes and preventing complications, Telcare creates an ecosystem of care that provides caregivers and disease managers with previously unavailable actionable clinical data. Telcare is a privately-held company funded by the Qualcomm Life Fund, Sequoia Capital, and founding investors. For more information, visit www.telcare.com.